Goldman Sachs Updates 'High Conviction' Buy List: Vertex Added, Interactive Brokers Removed

Goldman Sachs updated its U.S. high-conviction stock list to 23 names, adding Vertex Pharmaceuticals while removing Interactive Brokers Group. The firm noted that while August saw summer market volatility, opportunities remain in companies undergoing fundamental changes. Vertex is highlighted for its potential in cystic fibrosis, pain management, and kidney disease treatments, while other stocks like DoorDash and TPG showed strong performance.